StonvexLoading…
StonvexStonvexStonvexCore line items from EBC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $37.15M | $134.09M | $96.63M | $63.66M |
Operating Income | $83.83M | $99.51M | $10.35M | $-83.62M |
Net Income | $65.26M | $88.22M | $-11.29M | $-117.43M |
EPS (Diluted) | $0.29 | $0.43 | $-0.06 | $-0.59 |
Total Assets | $30.63B | $30.59B | $25.46B | $25.46B |
Total Liabilities | $26.35B | $26.25B | $21.65B | $21.77B |
Cash & Equivalents | $331.56M | $316.87M | $410.41M | $553.51M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 232.29M | 235.65M | 211.52M | 211.46M |